ASML Holding N.V. (ASML)

Revance Therapeutics Revenue

ASML Holding had revenue of 7.69B EUR in the quarter ending June 29, 2025, with 23.21% growth. This brings the company's revenue in the last twelve months to 32.16B, up 26.41% year-over-year. In the year 2024, ASML Holding had annual revenue of 28.26B with 2.56% growth.

• Revenue (ttm): 32.16B EUR
• Revenue Growth: +26.41%
• P/S Ratio: 7.06
• Revenue / Employee: 751,725 EUR
• Employees: 42,786
• Market Cap: 266.08B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.26B	704.40M	2.56%
Dec 31, 2023	27.56B	6.39B	30.16%
Dec 31, 2022	21.17B	2.56B	13.77%
Dec 31, 2021	18.61B	4.63B	33.14%
Dec 31, 2020	13.98B	2.16B	18.26%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.